







Session Two: Current State of Clinical Trials in New-Onset T1D
A Talk by Matthias von Herrath , Tadej Battelino , Joshua A. Vieth, PhD , Ulf Hannelius , Carla Greenbaum , Carmella Evans-Molina, MD, PhD , Lauren Wood Heickman, MD and Laura Knecht, MD
About this Talk
In this session we will discuss the current state of clinical trials in new-onset T1D reviewing lessons learned, the impact of new technologies such as CGMs and insulin-pumps, and the inherent challenges of conducting clinical trials in this space.
- Topic One: What’s Been Done and What Does It Tell Us?
- Topic Two: The Impact of Technology on Conduct of Trials
- Topic Three: Challenges of Conducting Trials in New-Onset T1D
- Panel Discussion: Conduct of Clinical Trials in T1D